These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23387974)

  • 1. Structural effects of TiO2 nanoparticles and doxorubicin on DNA and their antiproliferative roles in T47D and MCF7 cells.
    Hekmat A; Saboury AA; Divsalar A; Seyedarabi A
    Anticancer Agents Med Chem; 2013 Jul; 13(6):932-51. PubMed ID: 23387974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of silver nanoparticles and doxorubicin combination on DNA structure and its antiproliferative effect against T47D and MCF7 cell lines.
    Hekmat A; Saboury AA; Divsalar A
    J Biomed Nanotechnol; 2012 Dec; 8(6):968-82. PubMed ID: 23030005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded NaYF4:Yb/Tm-TiO2 inorganic photosensitizers for NIR-triggered photodynamic therapy and enhanced chemotherapy in drug-resistant breast cancers.
    Zeng L; Pan Y; Tian Y; Wang X; Ren W; Wang S; Lu G; Wu A
    Biomaterials; 2015 Jul; 57():93-106. PubMed ID: 25913254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
    Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
    Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
    Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
    Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy.
    Misra R; Sahoo SK
    Eur J Pharm Sci; 2010 Jan; 39(1-3):152-63. PubMed ID: 19961929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
    Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titanium dioxide nanoparticles preferentially bind in subdomains IB, IIA of HSA and minor groove of DNA.
    Ali K; Abul Qais F; Dwivedi S; Abdel-Salam EM; Ansari SM; Saquib Q; Faisal M; Al-Khedhairy AA; Al-Shaeri M; Musarrat J
    J Biomol Struct Dyn; 2018 Aug; 36(10):2530-2542. PubMed ID: 28753123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted sonocatalytic cancer cell injury using avidin-conjugated titanium dioxide nanoparticles.
    Ninomiya K; Fukuda A; Ogino C; Shimizu N
    Ultrason Sonochem; 2014 Sep; 21(5):1624-8. PubMed ID: 24717690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-shell structured Fe3O4@TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer.
    Shen S; Wu L; Liu J; Xie M; Shen H; Qi X; Yan Y; Ge Y; Jin Y
    Int J Pharm; 2015; 486(1-2):380-8. PubMed ID: 25841570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles.
    Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z
    Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
    Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
    Dong DW; Tong SW; Qi XR
    J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice.
    Iqbal H; Razzaq A; Uzair B; Ul Ain N; Sajjad S; Althobaiti NA; Albalawi AE; Menaa B; Haroon M; Khan M; Khan NU; Menaa F
    Materials (Basel); 2021 Jun; 14(12):. PubMed ID: 34201266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4-targeted Nanoparticles Reduce Cell Viability, Induce Apoptosis and Inhibit SDF-1α Induced BT-549-Luc Cell Migration In Vitro.
    Chittasupho C; Kewsuwan P; Murakami T
    Curr Drug Deliv; 2017; 14(8):1060-1070. PubMed ID: 28215173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.